In The News

Health Care Partner Comments on New FDA Rules for Institutional Review Boards

Practices: Health Care

On April 4, an article published by Bloomberg BNA’s Medical Research Law & Policy Report quotes health care partner Mark Barnes discussing a direct final rule and a proposed rule issued by the Food and Drug Administration to clarify regulatory language on FDA authority to restrict the activities of an institutional review board.

Cookie Settings